December 17th 2025, 10:00pm
Actor Dave Coulier, best known for his role in the sitcom “Full House,” recently sat down with CURE to discuss facing cancer for the second time.
December 17th 2025, 8:18pm
The FDA granted regular approval to treatment with Rubraca for some adult patients with previously-treated metastatic castration-resistant prostate cancer.
December 17th 2025, 8:00pm
At CURE, we strive to provide insight, education and inspiration for patients, survivors and caregivers at every stage of the cancer journey.
December 17th 2025, 6:00pm
CURE contributor Brian Sluga discusses his new memoir, “The Shriek I Do Remember.”
December 17th 2025, 5:00pm
Padcev plus Keytruda demonstrated clinically meaningful and statistically significant improvements in event-free survival and overall survival for MIBC.
December 17th 2025, 4:00pm
The FDA granted orphan drug designation to GSK’227, now known as risvutatug rezetecan, for the treatment of small-cell lung cancer.
December 17th 2025, 2:00pm
Jace Yawnick, now in remission from non-Hodgkin lymphoma, is navigating the world of mental health one day at a time.
December 16th 2025, 10:00pm
At the 2025 ASH Annual Meeting and Exposition, researchers presented new findings that may meaningfully affect how patients with blood cancers are treated.
December 16th 2025, 9:00pm
Gastric cancer care highlights eating difficulties, weight loss and side effects showing why nutrition support and clinical trials are key
December 16th 2025, 8:00pm
After beginning treatment for stage 3 inflammatory breast cancer, Lindsey Gunter started experiencing chemotherapy side effects so intense she was unable to walk.
‘Full House’ Star Dave Coulier Talks Tongue Cancer Diagnosis
FDA Grants Regular Approval to Rubraca for Some With Prostate Cancer
Education and Inspiration Across the Cancer Journey
Testicular Cancer Survivor Shares Story of Courage in New Book